Back to RXRX
Cambridge Investment Research Advisors, Inc. → RXRX
Cambridge Investment Research Advisors, Inc. RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
6
Latest value
$209K
Q3 2026
Peak value
$688K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $688K |
| Q4 2025 | $302K |
| Q1 2026 | $212K |
| Q2 2026 | $226K |
| Q2 2026 | $226K |
| Q3 2026 | $209K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $209K | 50.6K | — | — |
| Q2 2026 | $226K | 61.6K | — | — |
| Q2 2026 | $226K | 61.6K | — | — |
| Q1 2026 | $212K | 68.9K | — | — |
| Q4 2025 | $302K | 74.0K | — | — |
| Q3 2025 | $688K | 141.1K | — | — |